AnnouncementMarch 15, 2024

Notice Regarding the Start of Business Operations at the New PHC Holdings Corporation Headquarters Office Location in Tokyo

As announced on August 31, 2023, PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) will relocate the headquarters functions of PHCHD and its subsidiary PHC Corporation to Dai-ichi Life Hibiya First (15th floor) on April 1, 2024.

We hereby announce the start date of business operations and the address of the new headquarters.

[Start date of operations]

April 1, 2024

[New headquarters address]

15F DAI-ICHI LIFE HIBIYA FIRST 1-13-2 Yurakucho,Chiyoda-ku, Tokyo
100-8403 Japan

[Main Phone / Fax numbers]

PHC Holdings Corporation  Phone : 03-5408-7280 / FAX: 03-3214-1080
PHC Corporation     Phone : 03-5408-7290 / FAX: 03-3214-1188

About PHC Holdings Corporation

PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., LSI Medience Corporation, Wemex Corporation, and Mediford Corporation. PHC Holdings Corporation and its subsidiaries, collectively known as PHC Group, develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, diagnostics and life sciences. The consolidated net sales in FY2022 were JPY 356.4 billion with global distribution of products and services in more than 125 countries and regions.
URL: www.phchd.com